Learn to select appropriate therapies while managing treatment side effects to improve outcomes for patients with progression of head and neck cancers.
This activity is intended for hematology/oncology specialists, surgeons, and pathologists.
The goal of this activity is to build healthcare professionals’ confidence in strategies for the individualized treatment of the patient with squamous cell carcinoma of the head and neck (SCCHN) that has progressed despite treatment, and to ensure that best practices are applied across a variety of clinical presentations.
Approximate Time to Complete: 30 minutes
Credit Available: Dec. 20, 2017 - Dec. 20, 2018
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Demonstrate improved performance associated with prescribing the appropriate regimen for a patient with SCCHN based on patient and tumor characteristics
- Demonstrate improved performance associated with ordering patient education for expected treatment-related adverse events